psalexa
P&S Market Research - A market research firm

Portal Hypertension Therapeutics Pipeline Analysis

Portal Hypertension Therapeutics Pipeline Analysis 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

Delivery : 1-2 Working Days
Report Code: LS11269
Available Format:

Portal hypertension is a disorder in which pressure in portal vein and tributaries is increased and portal pressure gradient is more than 10 mmHg. The portal pressure gradient predicts the decompensation of cirrhosis, hepatocellular carcinoma, and development of varices. The development of gastroesophageal varices, one of the consequences of portal hypertension, can cause variceal haemorrhage. There are three types of portal hypertension, including intrahepatic, post-hepatic and pre-hepatic. Portal hypertension is one of the complications of the liver disease. Aga Khan University is in the process of developing carvedilol as a non-selective beta-adrenergic receptor blocker (β1, β2) and an alpha-adrenergic receptor blocker (α1), for the treatment of portal hypertension. Ferring Pharmaceuticals, Inc. is in the process of developing FE 204205 as a vasopressin 1a receptor agonist for the treatment of portal hypertension. Some companies and universities having the pipeline of portal hypertension include Ferring Pharmaceuticals, Inc., Cumberland Pharmaceuticals, Inc., and others.

The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials. Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 3250
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 4000
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 7750

Pre-Purchase Enquiry